Condition: B-cell Non-Hodgkin Lymphoma (B-NHL) · Sponsor: Regeneron Pharmaceuticals
This study is researching an investigational drug, odronextamab, in adult patients B-cell non-Hodgkin's lymphoma (B-NHL). The main purpose of this study is to assess the effectiveness of odronextamab in destroying cancer cells and to learn more about the safety of odronextamab. The study is looking at several other research questions, including: * To see if odronextamab works to destroy cancer cells * Side effects that may be experienced by people taking odronextamab * How odronextamab works in the body * How much odronextamab is present in the blood
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Rush University Medical Center | Chicago, Illinois, United States | — |
| University of Iowa | Iowa City, Iowa, United States | — |
| Norton Cancer Institute | Louisville, Kentucky, United States | — |
| Tufts Medical Center | Boston, Massachusetts, United States | — |
| Beth Israel Deaconess Medical Center | Boston, Massachusetts, United States | — |
| Mayo Clinic - Rochester | Rochester, Minnesota, United States | — |
| John Theurer Cancer Center at Hackensack UMC | Hackensack, New Jersey, United States | — |
| Weill Cornell Medical College New York Presbyterian Hospital | New York, New York, United States | — |
| Stony Brook University Hospital | Stony Brook, New York, United States | — |
| Wake Forest Baptist Medical Center | Winston-Salem, North Carolina, United States | — |
| Cleveland Clinic Foundation | Cleveland, Ohio, United States | — |
| Stephenson Cancer Center | Oklahoma City, Oklahoma, United States | — |
+ 107 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.